BIODESIX INC cotiza a 25.36 USD y tiene una capitalización bursátil de $268M. En los últimos 12 meses ha facturado $103M con un margen de flujo de caja libre del -26.6%. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Biodesix, Inc. operates as a diagnostic solutions company. The company offers blood-based lung tests, including Nodify XL2 and Nodify CDT tests markets as Nodify Lung Nodule Risk Assessment testing to assess the risk of lung cancer and help in identifying the appropriate treatment pathway and help physicians in reclass…
| Periodo | 2026-11 | 2026-08 | 2026-05 | 2026-02 |
|---|---|---|---|---|
| Real | — | $-0.71 | $-0.81 | $-0.49 |
| Estimado | $-0.75 | $-0.90 | $-1.10 | $-0.87 |
| Sorpresa | — | +21.1% | +26.4% | +43.7% |
| Métrica | BDSX | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | — | 57.0% | — |
| Operating Margin | -31.5% | -38.6% | +7.1% |
| Net Margin | -39.9% | -33.6% | -6.3% |
| FCF Margin | -26.6% | -13.9% | -12.7% |
| ROE | — | -40.4% | — |
| ROA | -40.3% | -32.0% | -8.3% |
| Current Ratio | 1.86 | 2.84 | -0.98 |
| Debt / Equity | -20.29 | 0.28 | -20.57 |